2. What should I know before I use Aimovig?
Do not use if you have had an allergic reaction to erenumab or any of the ingredients
listed at the end of this leaflet.
Talk to your doctor if you have any other medical conditions, take any other medicines,
are pregnant, plan to become pregnant or are breastfeeding. Aimovig is not suitable
for children under 18 years. For more information, see Section
2. What should I know before I use Aimovig? in the full CMI
3. What if I am using other medicines?
Some medicines may interfere with Aimovig and affect how it works. A list of these
medicines is in Section 3. What if I am taking other medicines? in the full CMI.
4. How do I use Aimovig?
The usual dose of Aimovig is 70 mg once every 4 weeks. Some patients may need to use
140 mg once every 4 weeks.
Aimovig is supplied as a pen that contains a dose of 70 mg or 140 mg for self-administration.
It is given as a single injection under the skin. Your doctor or pharmacist will train
you or your care giver on how to use the Aimovig pen. More instructions on how to
use Aimovig can be found in Section
4. How do I use Aimovig? in the full CMI.
5. What should I know while using Aimovig?
|
Things you should do
|
Remind any doctor, dentist or pharmacist you visit that you are using Aimovig.
After 8 to 12 weeks of starting Aimovig visit your doctor who will assess your progress.
Schedule 3 to 6 monthly visits with your doctor to monitor your treatment.
|
|
Things you should not do
|
Do not stop using this medicine or lower the dose suddenly. Your symptoms may return.
Do not use this medicine to treat any other condition.
|
|
Driving or using machines
|
Aimovig is not expected to affect driving or ability to use machinery.
|
|
Looking after your medicine
|
Store your Aimovig in the refrigerator at 2°C to 8°C. Keep it in the original carton.
Do not shake or freeze.
After you take Aimovig out of the refrigerator, keep it in the carton and at room
temperature (up to 30°C). Use within 7 days. Do not return to the refrigerator after
it has reached room temperature.
|
6. Are there any side effects?
Common side effects include constipation, itching, muscle spasms, pain, redness and/or
swelling at the injection site, hair loss, mouth or lip sores. Serious side effects
are allergic reactions such as rash or swelling, or sometimes difficulty breathing.
For more information, including what to do if you have any side effects, see Section
6. Are there any side effects? in the full CMI.
This medicine is subject to additional monitoring. This will allow quick identification
of new safety information. You can help by reporting any side effects you may get.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems .
Active ingredient(s): erenumab
Full Consumer Medicine Information (CMI)
This leaflet provides important information about using Aimovig.
You should also speak to your doctor or pharmacist if you would like further information
or if you have any concerns or questions about using Aimovig.
Where to find information in this leaflet:
1. Why am I using Aimovig?
Aimovig contains the active ingredient erenumab. It belongs to a group of medicines
called anti CGRP antibodies. CGRP stands for calcitonin gene related peptide.
Aimovig works by blocking the activity of the CGRP molecule, which has been linked
to migraine.
Aimovig is used to treat migraine. It is intended to reduce the number of days each
month you have a migraine.
2. What should I know before I use Aimovig?
Warnings
Do not use Aimovig if:
you are allergic to erenumab, or any of the ingredients listed at the end of this
leaflet.
Always check the ingredients to make sure you can use this medicine.
Allergic reactions can happen within minutes, but some may happen more than one week
after using Aimovig.
Some of the symptoms of an allergic reaction may include:
shortness of breath
wheezing or difficulty breathing
swelling of the face, lips, tongue or other parts of the body
rash, itching or hives on the skin.
Do not give this medicine to a child or adolescent under the age of 18 years as Aimovig
has not been studied in this age group.
Do not use this medicine after the expiry date printed on the pack or if the packaging
is torn or shows signs of tampering.
If it has expired or is damaged, return it to your pharmacist for disposal.
Check with your doctor if you:
have any other medical conditions for example:
problems with your kidney
problems with your liver
high blood pressure
history of constipation.
Aimovig contains sodium. The content is less than 1 mmol sodium (23 mg) per dose,
this means it is essentially "sodium free" and should not affect a sodium-controlled
diet.
If you have not told your doctor about any of the above, tell him/her before you start
using Aimovig.
During treatment, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. For more information, see
Section 6. Are there any side effects?
Pregnancy and breastfeeding
Tell your doctor if are pregnant or plan to become pregnant.
Aimovig has not been studied in pregnant women. It is not known whether Aimovig could
harm your unborn baby. Your doctor can discuss with you the risks and benefits involved.
Tell your doctor if you are breastfeeding.
It is not known whether Aimovig passes into breast milk. Your doctor will help you
decide whether you should stop breast feeding or stop taking Aimovig.
3. What if I am taking other medicines?
Tell your doctor or pharmacist if you are taking any other medicines, including any
medicines, vitamins or supplements that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Tell your doctor if you are taking other medicines for migraine.
Some medicines may interfere with Aimovig and affect how it works.
4. How do I use Aimovig?
Follow all directions given to you by your doctor or pharmacist carefully.
They may differ from the information contained in this leaflet. If your doctor has
prescribed Aimovig with another migraine medicine, follow your doctor's instructions
on how to use these medicines together.
If you do not understand the instructions in the box, ask your doctor or pharmacist
for help.
How much and when to use Aimovig
Each pen contains 70 mg or 140 mg Aimovig. The usual dose of Aimovig is 70 mg once
every 4 weeks. Your doctor might decide you need 140 mg once every 4 weeks. Use Aimovig
exactly as instructed by your doctor.
70 mg/mL solution for injection
If your doctor prescribed the 70 mg dose you should use one 70 mg/mL pen once every
4 weeks, injected under the skin in your abdomen, thigh or upper arm.
However, if your doctor prescribed the 140 mg dose you can use two 70 mg pens once
every 4 weeks. The second injection must be given immediately after the first.
140 mg/mL solution for injection
If your doctor prescribed the 140 mg dose, you will use one 140 mg/mL pen once every
4 weeks, injected under the skin in your abdomen, thigh, or upper arm.
Make sure that you inject the entire contents of each pen.
How to use Aimovig
Aimovig is injected under the skin.
Your doctor or pharmacist will give you or your caregiver training in the right way
to prepare and inject Aimovig. Do not try to inject Aimovig until you have completed
this training.
Follow the “Instructions for Use” leaflet in the pack.
If you forget to use Aimovig
Aimovig should be used regularly on the same day each month. If you miss your dose
at the usual time, use it as soon as possible. Your next dose is then taken one month
from the date of your last dose.
Contact your doctor or pharmacist if you are not sure when to take your next dose.
Do not use a double dose to make up for the dose that you missed.
If you use too much Aimovig
If you think that you have used too much Aimovig, you may need medical attention.
You should immediately:
phone the Poisons Information Centre
(by calling
13 11 26), or
contact your doctor, or
go to the Emergency Department at your nearest hospital.
You should do this even if there are no signs of discomfort or poisoning.
5. What should I know while using Aimovig?
Things you should do
After 8 to 12 weeks of starting Aimovig visit your doctor who will assess your progress.
Some effects of Aimovig such as high blood pressure can only be checked by a doctor.
Schedule a visit with your doctor every 3 to 6 months to check your progress.
If you are about to start on any new medicine, remind your doctor and pharmacist that
you are using Aimovig.
Tell any other doctors, dentists, and pharmacists who treat you that you are using
this Aimovig.
If you become pregnant while taking this medicine, tell your doctor immediately.
Things you should not do
Do not use Aimovig to treat any other complaints unless your doctor tells you to.
Do not give your medicine to anyone else, even if they have the same condition as
you.
Do not stop using your medicine or lower the dosage without checking with your doctor.
Your symptoms may return if you stop the treatment.
Driving or using machines
Aimovig is not expected to affect driving or ability to use machinery.
Drinking alcohol
Tell your doctor if you drink alcohol regularly.
Looking after your medicine
Follow the instructions in the carton on how to take care of your medicine properly.
Keep the pen in the outer carton until it is time to use it. If you take the pen out
of the carton it may not keep well.
Keep pens in a refrigerator (2°C - 8°C). Do not freeze. Do not shake.
After Aimovig has been taken out of the refrigerator, it can be kept at room temperature
(up to 30°C) in the outer carton box and must be used within 7 days. Do not put Aimovig
back in the refrigerator after it has reached room temperature.
Store it in a cool dry place away from moisture, heat or sunlight; for example, do
not store it:
in the bathroom or near a sink, or
in the car or on window sills.
Keep it where young children cannot reach it.
A locked cupboard at least one-and-a-half metres above the ground is a good place
to store medicines.
When to discard your medicine
Aimovig pen is for single use only.
If your doctor tells you to stop using this medicine or the expiry date has passed,
ask your pharmacist what to do with any medicine that is left over.
Do not use this medicine after the expiry date which is stated on the label and carton
after EXP. The expiry date refers to the last day of that month.
Getting rid of any unwanted medicine
If you no longer need to use this medicine or it is out of date, take it to any pharmacy
for safe disposal.
Do not throw away any medicines via wastewater or household waste.
6. Are there any side effects?
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
See the information below and, if you need to, ask your doctor or pharmacist if you
have any further questions about side effects.
Less serious side effects
Serious side effects
Tell your doctor or pharmacist if you notice anything else that may be making you
feel unwell.
Other side effects not listed here may occur in some people. Some side effects may
not give you any symptoms and can only be found when tests are done. For example,
the development or worsening of high blood pressure.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at
www.tga.gov.au/reporting-problems . By reporting side effects, you can help provide more information on the safety of
this medicine.
Always make sure you speak to your doctor or pharmacist before you decide to stop
using any of your medicines.
7. Product details
This medicine is only available with a doctor's prescription.
What Aimovig contains
|
Active ingredient (main ingredient)
|
Erenumab
|
|
Other ingredients
(inactive ingredients)
|
Sucrose
Polysorbate 80
Sodium hydroxide
Glacial acetic acid
Water for injections.
|
|
Potential allergens
|
None identified.
|
|
Other information
|
This medicine does not contain lactose, gluten, tartrazine or any other azo dyes.
|
Do not take this medicine if you are allergic to any of these ingredients.
What Aimovig looks like
Aimovig is supplied as single use pre-filled pens:
Aimovig 70 mg solution for injection in pre-filled pen: AUST R 289959.
Aimovig 140 mg solution for injection in pre-filled pen: AUST R 309205.
Each pack contains one pre-filled pen.
Aimovig is a clear to opalescent, colourless to light yellow solution, practically
free from particles. Do not use the solution if you notice that it contains easily
visible particles, is cloudy or is distinctly yellow.
Who distributes Aimovig?
Aimovig is supplied in Australia by:
Novartis Pharmaceuticals Australia Pty Limited
ABN 18 004 244 160
Level 25, Victoria Cross Tower
155 Miller Street
North Sydney NSW 2060
Telephone 1 800 671 203
This leaflet was prepared in July 2026.
® Registered trademark. © Copyright 2026.
(aimpen300726c.doc based on PI aim300726i.doc)